Last reviewed · How we verify

NCT04555759

Validity and Reliability of the 2-minute Walk Test in Individuals With a Spinal Cord Injury

Completed NA Last updated 18 July 2023
What this trial tests

NA trial testing 2-minute walk test in Spinal Cord Injuries in 50 participants. Completed in 21 June 2021.

Timeline
16 January 2020
Primary endpoint
21 June 2021
21 June 2021

Quick facts

Lead sponsorUniversity of Zurich
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment50
Start date16 January 2020
Primary completion21 June 2021
Estimated completion21 June 2021
Sites2 locations across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

18 and older, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There exist a variety of outcome measures to asses gait function in individuals with a spinal cord injury (SCI). The most established measures are the 10-meter walk test (10MWT) and the 6-minute walk test (6mWT). They are used to assess treatment efficacy and recovery of gait function in individuals with SCI. However, the 10MWT is appropriate for poor walkers but not sensitive in good walkers and the 6mWT can be time-consuming and is very demanding for severely impaired patients. Therefore the 2-minute walk test (2mWT) has gained more attention in the SCI field. The 2mWT has been established in numerous neurological diseases and has shown to correlate with the 6mWT in patients with neuromuscular disease, multiple sclerosis and stroke. Though the 2mWT has not yet been validated in individuals with SCI. A limitation that affects all timed walking tests is that they suffer from limited information about gait quality (i.e. how walking function is achieved). Being able to receive information on the gait quality of a patient can help to understand the underlying mechanisms of walking improvements after an intervention (e.g. compensation vs recovery). The research in the field of inertia measuring units (IMU) develops and advances very rapidly at the moment resulting in the possibility to perform a gait analysis with a simple IMU setup. However, the reliability of such measurement setups has not yet been shown in individuals with SCI. The primary aim of this study is to test the validity and reliability of the 2mWT in the SCI population. Additionally, it will be investigated if a simple sensor setup can give additional reliable information about the gait pattern of individuals with SCI.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Validity and reliability of the 2-minute walk test in individuals with spinal cord injury.
    Willi R, Widmer M, Merz N, Bastiaenen CHG, et al · · 2023 · cited 11× · PMID 35999254 · DOI 10.1038/s41393-022-00847-1
  2. Reliability of patient-specific gait profiles with inertial measurement units during the 2-min walk test in incomplete spinal cord injury.
    Willi R, Werner C, Demkó L, de Bie R, et al · · 2024 · cited 6× · PMID 38321085 · DOI 10.1038/s41598-024-53301-y

Verify or expand the search:

Other trials of 2-minute walk test

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04555759.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing